| abstract |
Claim 1: Use of a nutritional composition comprising: A sphingophospholipids, preferably sphingomyelin, and / or at least one sphingophospholipid degradation product selected from the group consisting of ceramide, lysosphingophospholipids, sphingoid phosphates, and free sphingoid bases, and B at least a non-digestible carbohydrate selected from the group consisting of fructo-oligosaccharides, galacto-oligosaccharides, gluco-oligosaccharides, arabino-oligosaccharides, mannan-oligosaccharides, xyl-oligosaccharides, fuco-oligosaccharides, arabinogalacto-oligosaccharides, glucomano-oligosaccharides, oligosaccharides, oligosaccharides oligosaccharides comprising sialic acid and oligosaccharides of uric acid to make a composition to normalize the intestinal microbiota in a human subject, to obtain a microbiota similar to that found in healthy and / or breastfeeding thin subjects fed with breast milk. |